Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun;41(6):2593-5.
doi: 10.1128/JCM.41.6.2593-2595.2003.

Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran

Affiliations

Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran

Mohammad Reza Abbaszadegan et al. J Clin Microbiol. 2003 Jun.

Abstract

The city of Mashhad is the capital of Khorasan, the northeastern province of Iran, which has been recognized as an area where human T-lymphotropic virus type 1 (HTLV-1) infection is endemic. All serum samples from blood donors are routinely screened for HTLV-1 by using enzyme-linked immunosorbent assay (ELISA). In the present study, 28,926 donors (81.86% male and 18.14% female) with a mean age of 32 years (range, 18 to 65 years) were screened in a 6 months period (July to December 1999). Of these donors in the primary screening, 228 (0.78%) tested positive by ELISA. The positive samples were confirmed by Western blot (WB) analysis. The WB results indicated that, of 228 positive ELISA specimens, 91.2% (208 specimens) were HTLV-1, 4.82% (11 specimens) were HTLV, 3.5% (8 specimens) were indeterminate, and 0.44% (1 specimen) was not confirmed. HTLV refers to samples in which the complete viral antigen banding patterns on WB strips were not present. In order to further evaluate the detection methodologies used, the HTLV-1-seropositive samples, the indeterminant samples, and/or HTLV samples were examined and confirmed by PCR. The HTLV samples were determined to be HTLV-1, the remaining samples were indeterminant, and the negative sample could not be confirmed for HTLV-1 by PCR. The prevalence of HTLV-1 infection in our study was 0.77% among blood bank donors, which reconfirms the city of Mashhad as an area where the virus is endemic compared to other regions in the world. The incidence was correlated with increasing age, and it was higher in females than in males.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Amplification of tax and LTR regions in blood donors. All 522- and 394-bp fragments were amplified from the tax and LTR regions of HTLV-1 genome, respectively. PCR products were electrophoresed in a 1.5% agarose gel, stained in ethidium bromide and photographed. Lane 1, negative control; lanes 2 and 3, blood donors; lane 4, MT-2 cell line DNA; lane 5, molecular weight marker; lanes 6 to 10, blood donors.
FIG. 2.
FIG. 2.
HTLV-1 seroprevalence by age group (in years) and gender among Mashhad blood donors. Lightly shaded bars, male; darkly shaded bars, female.

Similar articles

Cited by

References

    1. Blattner, W. A., K. Takatsuki, and R. C. Gallo. 1983. Human T-cell leukemia-lymphoma virus and adult T-cell leukemia. JAMA 250:1074-1080. - PubMed
    1. Gessain, A., E. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet ii:407-410. - PubMed
    1. Heneine, W., R. F. Khabbaz, R. B. Lal, and J. E. Kaplan. 1992. Sensitive and specific polymerase chain reaction assay for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection in HTLV-I/II-seropositive individuals. J. Clin. Microbiol. 30:1605-1607. - PMC - PubMed
    1. Hjelle, B., R. Mills, G. Mertz, and S. Swenson. 1990. Transmission of HTLV-1 via blood transfusion. Vox Sang. 59:119-122. - PubMed
    1. Kalyanaraman, V. S., M. G. Sarngadharan, B. Poiesz, F. W. Ruscetti, and R. C. Gallo. 1981. Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J. Virol. 38:906-915. - PMC - PubMed

Substances